Table 5.
Comparative study populations.
| Study | Population Studied |
|---|---|
| TWCC | Individuals referred to hematologists at TWCC, Salina, KS for workup of a new diagnosis of anemia between August 2015 and May 2019 (excluded, if prior diagnosis or treatment of non-hematologic malignancy). |
| Guralnik et al.5 | Participants in Third National Health and Nutrition Examination Survey (NHANES III); older than 65 and anemic. |
| Price et al.6 | Patients older than 65 and anemic referred between March 2006 and January 2010 to Stanford Hospital and Clinics and Veteran Affairs Palo Alto Health Care Systems outpatient hematology clinics; not institutionalized; ECOG performance ≥ 2; excluded, if had received any red cell transfusion or erythropoiesisstimulating agent within prior three months, had end-stage liver disease, were dialysis-dependent, had known diagnosis of hematologic malignancy, had predicted survival less than three months due to other comorbidities, or were unlikely to comply with protocol. |
| Artz and Thirman7 | Patients older than 65 seen in anemia referral clinic from January 2005 – June 2009 at University of Chicago Hematology Clinic; excluded for erythropoietin-stimulating agent hyporesponsiveness, known hematologic malignancy, or cancer chemotherapy or radiation therapy completed within prior six months. |
| Ania et al.8 | Individuals in Olmstead County, Minnesota older than 65 years old with newly recognized cases of anemia during 1986. |